Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 1711-1717, June 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denlinger, R. H.
Right arrow Articles by Swenberg, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denlinger, R. H.
Right arrow Articles by Swenberg, J. A.

Neoplasms in Purebred Boxer Dogs following Long-Term Administration of N-Methyl-N-nitrosourea1

R. H. Denlinger2,3, A. Koestner and J. A. Swenberg2

Department of Veterinary Pathobiology, The Ohio State University, Columbus, Ohio 43210

The carcinogenicity of N-methyl-N-nitrosourea (MNU) has been demonstrated in several species for a variety of tissues, particularly the nervous system. Boxer dogs, a breed with a high incidence of spontaneous tumors (including brain tumors), were exposed to MNU to determine their susceptibility to MNU and to compare the induced tumors with the types of tumors reported in the literature.

Twenty purebred Boxer dogs were given weekly i.v. injections of MNU, 5 mg/kg, for 36 weeks and were observed for approximately 3 years for the development of neoplasia. Nineteen of 20 dogs developed neoplasms 19 to 36.5 months after the first injection. The mean latent period was 30 ± 5 (S.D.) months. All tumor-bearing dogs had 2 or more neoplasms, including metastases, and 14 dogs had tumors of more than 1 tumor type. Malignant neurinomas of the small intestine were present in 11 dogs, and poorly differentiated sarcomas of the small intestine were found in 6 dogs. Metastasis occurred to liver, spleen, lymph nodes, lung, and adrenal. Two cases of malignant neurinoma developed in the heart, and 1 each developed in the stomach and colon. Two welldifferentiated neurinomas occurred in the small intestine, and 1 each occurred in a spinal root, the stomach, and the colon.

The high incidence rate, young age of development, and unique tumor types clearly distinguished the tumors from spontaneous tumors of Boxers. Although the lack of brain involvement was unexplained, MNU had a neurooncogenic effect on the peripheral nerves of the gastrointestinal tract.

1 Supported in part by Grants CA11224, RR05463, and GM1052 from the NIH. Presented in part at the annual meeting of the American Association for Cancer Research, Toronto, Ontario, Canada, May 1976 (9).

2 Present address: Pathology and Toxicology Research Unit, The Upjohn Company, Kalamazoo, Mich. 49001.

3 To whom requests for reprints should be addressed, at Pathology and Toxicology Research Unit, The Upjohn Co., 301 Henrietta Street, Kalamazoo, Mich. 49001.

Received 12/12/77. Accepted 3/14/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.